$93.53
1.39%
NYSE, Nov 13, 04:00 pm EST. Closed.
ISIN
US0126531013
Symbol
ALB
Sector
Industry

Albemarle Stock price

$93.53
-4.12 4.22% 1M
-107.41 53.45% 6M
-47.91 33.87% YTD
-21.04 18.36% 1Y
-20.66 18.09% 3Y
-177.76 65.52% 5Y
+16.45 21.34% 10Y
+59.78 177.08% 20Y
NYSE, Closing price Fri, Nov 13 2026
-1.32 1.39%
ISIN
US0126531013
Symbol
ALB
Sector
Industry

AI Insights on Albemarle Insights AI Insights on Albemarle

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is Albemarle a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,087 stocks worldwide.

Key metrics

Basic
Market capitalization
$11.0b
Enterprise Value
$11.1b
Net debt
$35.4m
Cash
$1.8b
Shares outstanding
118.0m
Valuation
P/E
21.6
P/S | estimate
1.8 | 1.8
EV/Sales | estimate
1.8 | 1.8
EV/FCF | ex SBC
7.7 | 7.9
P/B
1.1
Dividends
DPS
$1.63
Yield 1Y | 5Y
1.7% | 1.0%
Growth 1Y | 5Y
0.6% | 0.9%
Payout 1Y | 3Y
-28.1% | -134.2%
Increased
25 Years
Financials
Revenue | estimate
$6.2b | $6.1b
EBITDA
$1.7b
EBIT
$1.0b
Net Income
$514.9m
Free Cash Flow | ex SBC
$1.4b | $1.4b
Growth
Revenue | estimate
24.4% | 18.9%
EBITDA
146.2%
EBIT
4,943.7%
Net Income
374.0%
Free Cash Flow
1,284.7%
Margin
Gross
25.9%
EBITDA
27.2%
EBIT
16.7%
Net
8.4%
Free Cash Flow | ex SBC
23.5% | 22.9%
Financial Health
Equity Ratio
58.2%
Return on Equity
-7.1%
ROCE
7.2%
ROIC
3.6%
Debt/Equity
0.2
Share-Based Compensation & Dilution
SBC | % of Revenue
$36.4m | 0.6%
SBC as % of FCF
2.5%
SBC Growth 1Y
1.9%
Share Count Growth 1Y
0.3%
Shareholder Yield
1.5%
More
EPS
$4.3
FCF per Share
$12.2
Short interest
0.1%
Employees
8k
Rev per Employee
$660.0k

Albemarle Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Albemarle forecast:

19x Buy
70%
8x Hold
30%

Analyst Opinions

27 Analysts have issued a Albemarle forecast:

Buy
70%
Hold
30%

Albemarle Events

Past Events
NOV
5
Q3 2026 Earnings Call
9 days ago
AUG
6
Q2 2026 Earnings Call
3 months ago
MAY
7
Q1 2026 Earnings Call
6 months ago
FEB
12
Q4 2025 Earnings Call
9 months ago
NOV
6
Q3 2025 Earnings Call
about one year ago

Financial data from Albemarle

Sep '26
+/-
%
6,153 6,153
24% 24%
100%
- Direct Costs 4,558 4,558
5% 5%
74%
1,595 1,595
162% 162%
26%
- Selling and Administrative Expenses 537 537
1% 1%
9%
- Research and Development Expense 33 33
44% 44%
1%
1,670 1,670
146% 146%
27%
- Depreciation and Amortization 646 646
2% 2%
10%
EBIT (Operating Income) EBIT 1,025 1,025
4,944% 4,944%
17%
Net Profit 515 515
374% 374%
8%

In millions USD.

Don't miss a Thing! We will send you all news about Albemarle directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Albemarle Stock News

Neutral
PRNewsWire
●
9 days ago
CHARLOTTE, N.C., Nov. 4, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the third quarter ended September 30, 2026.
Neutral
PRNewsWire
●
19 days ago
CHARLOTTE, N.C., Oct. 26, 2026 /PRNewswire/ -- The Board of Directors of Albemarle Corporation (NYSE: ALB) today announced that it declared a quarterly common stock dividend of $0.41 per share.
More Albemarle News

Company Profile

Albemarle Corp. is a specialty company, which engages in developing, manufacturing, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment engages in developing and manufacture of basic lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties and reagents. The Bromine Specialties segment consists of bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Catalysts segment contain two product lines: clean fuels technologies, which is primarily composed of hydro processing catalysts, and heavy oil upgrading that comprises of fluidized catalytic cracking catalysts and additives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Head office United States
CEO Mr. Masters
Employees 7,800
Founded 1993
Website www.albemarle.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today